Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 319-323 , March 2010

Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction

  • Lawrence Koutcher

      Affiliations

    • Department of Radiation Oncology
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY 10065, USA.
  • ,
  • Åse Ballangrud

      Affiliations

    • Department of Medical Physics
  • ,
  • Peter G. Cordeiro

      Affiliations

    • Department of Surgery, Plastic and Reconstructive Service
  • ,
  • Beryl McCormick

      Affiliations

    • Department of Radiation Oncology
  • ,
  • Margie Hunt

      Affiliations

    • Department of Medical Physics
  • ,
  • Kimberly J. Van Zee

      Affiliations

    • Department of Surgery; and
  • ,
  • Clifford Hudis

      Affiliations

    • Department of Medicine, Memorial Sloan-Kettering Cancer Center, NY, USA
  • ,
  • Kathryn Beal

      Affiliations

    • Department of Radiation Oncology

Received 22 February 2009 ,Revised 22 November 2009 ,Accepted 17 December 2009.

References 

  1. Fowble B, Glick J, Goodman R. Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 1988;15:627–631
  2. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish breast cancer cooperative group DBCG 82c randomised trial. Lancet. 1999;353:1641–1648
  3. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial. N Engl J Med. 1997;337:949–955
  4. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116–126
  5. Clarke M, Collins R, Darby S, et al. Early breast cancer trialists’ collaborative group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  6. Cordeiro PG, Pusic AL, Disa JJ, McCormick B, Van Zee K. Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg. 2004;113:877–881
  7. Magarey CJ. Aspects of the psychosocial management of breast cancer. Med J Aust. 1988;148:239–242
  8. Miller MJ. Immediate breast reconstruction. Clin Plast Surg. 1998;25:145–156
  9. Motwani SB, Strom EA, Schechter NR, et al. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:76–82
  10. Schechter NR, Strom EA, Perkins GH, et al. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol. 2005;28:485–494
  11. Chawla AK, Kachnic LA, Taghian AG, Niemierko A, Zapton DT, Powell SN. Radiotherapy and breast reconstruction: complications and cosmesis with tram versus tissue expander/implant. Int J Radiat Oncol Biol Phys. 2002;54:520–526
  12. Whitfield GA, Horan G, Irwin MS, Malata CM, Wishart GC, Wilson CB. Incidence of severe capsular contracture following implant-based immediate breast reconstruction with or without postoperative chest wall radiotherapy using 40 Gy in 15 fractions. Radiother Oncol. 2009;90:141–147
  13. Wright JL, Cordeiro PG, Ben-Porat L, et al. Mastectomy with immediate expander implant reconstruction, adjuvant chemotherapy and radiation for stage II-III breast cancer: Treatment intervals and clinical outcomes. Int J Radiat Oncol Biol Phys. 2008;70:43–50
  14. Damast S, Beal K, Ballangrud A, et al. Do metallic ports in tissue expanders affect postmastectomy radiation delivery?. Int J Radiat Oncol Biol Phys. 2006;66:305–310
  15. Chui CS, Hong L, McCormick B. Intensity-modulated radiotherapy technique for three-field breast treatment. Int J Radiat Oncol Biol Phys. 2005;62:1217–1223
  16. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  17. Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992;22:887–896
  18. Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99:365–375
  19. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for NSCLC. Int J Radiat Oncol Biol Phys. 1999;45:323–329
  20. Spierer MM, Hong LX, Wagman RT, Katz MS, Spierer RL, McCormick B. Postmastectomy CT-based electron beam radiotherapy: dosimetry, efficacy, and toxicity in 118 patients. Int J Radiat Oncol Biol Phys. 2004;60:1182–1189
  21. NCCN clinical practice guidelines in oncology. V.2.2008. <www.nccn.org>.

PII: S0167-8140(09)00661-6

doi: 10.1016/j.radonc.2009.12.003

Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 319-323 , March 2010